Detalhe da pesquisa
1.
IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer.
Proc Natl Acad Sci U S A
; 119(31): e2201376119, 2022 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35878022
2.
Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells.
Int J Mol Sci
; 18(1)2016 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28035994
3.
Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy.
Nat Commun
; 13(1): 4118, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35840558
4.
Stromal induction of BRD4 phosphorylation Results in Chromatin Remodeling and BET inhibitor Resistance in Colorectal Cancer.
Nat Commun
; 12(1): 4441, 2021 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34290255
5.
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy.
Nat Commun
; 11(1): 5878, 2020 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33208750
6.
Diphenhydramine induces melanoma cell apoptosis by suppressing STAT3/MCL-1 survival signaling and retards B16-F10 melanoma growth in vivo.
Oncol Rep
; 36(6): 3465-3471, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27779705